Search for the latest oncology news by tumour type
Existing drugs could benefit patients with bone cancer, genetic study suggests
A subgroup of patients with osteosarcoma – a form of bone cancer – could be…
Browsing: Tumour Stream
Tiny nanoparticles offer significant potential in detecting and treating disease
Tiny nanoparticles offer significant potential in detecting and treating disease, according to a new review.…
Study shows biomarkers can predict which ER-positive breast cancer patients respond best to first-line therapy
Two challenges in treating patients with estrogen-positive breast cancer (ER+) have been an inability to…
EHA: Cerdulatinib demonstrates rapid tumour responses in a phase 2 study for relapsed/refractory NHL
Cerdulatinib is an oral, dual Syk-JAK inhibitor with a unique mechanism of action. It inhibits…
EHA: Delayed exposure to common infections causes acute leukaemia of childhood
Acute leukaemia is the most common cancer in childhood and the incidence is increasing especially…
EHA: Early metabolic response determination by FDG-PET allows substantial reduction of chemo and toxicity for advanced stage Hodgkin lymphoma
Hodgkin lymphoma is the most common malignancy of young adults. Intensive chemotherapy with 8 or…
Identifying similarities between next-generation prostate cancer drugs
Researchers have shown for the first time how a class of advanced prostate cancer drugs…
Combination approach improves power of new cancer therapy
An international research team has found a way to improve the anti-cancer effect of a…
Three charts on cancer rates in Australia: where liver cancer is on the rise while other types fall
Terry Slevin, Cancer Council Australia Liver cancer is a looming health threat in Australia, recent…
Home bladder cancer tests set for clinical trial
A leading car sensor manufacturer is developing a device to radically simplify bladder cancer testing.…